The global large volume parenteral (LVP) market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by factors such as increasing prevalence of chronic diseases and rising demand for LVPs in emerging economies.
The global LVP market can be segmented on the basis of type, application, and region. On the basis of type, the global LVP market can be segmented into soft bag LVPs, plastic bottle LVPs, and glass bottle LVPs. Soft bag LVPs are expected to account for a major share in the global large volume parenteral (LVP) market owing to their advantages such as ease in handling and storage; however plastic bottles are expected to witness significant growth due to their cost-effectiveness over glass bottles. On the basis of application, the global large volume parenteral (LVP) market can be segmented into basic infusion therapy and therapeutic infusion therapy; while basic infusion therapy is expected to account for a major share in this market owing its wide usage across various applications such as blood transfusion or administration of fluids or nutrients intravenously; therapeutic infusion therapy is also projected to witness significant growth due its increasing usage across various applications such as chemotherapy or dialysis treatment which require high volumes per session with low frequency dosing intervals. The regional segments include North America, Latin America, Europe, Asia Pacific & Middle East & Africa regions which are further sub-segmented into countries like US, Canada Mexico Brazil Russia China India Japan South Korea Australia Saudi Arabia UAE Qatar Kuwait Oman Saudi Arabia Qatar Kuwait Oman UAE Australia New Zealand Chile Argentina Peru Colombia Ecuador Venezuela Bolivia Uruguay Paraguay Jamaica Trinidad & Tobago Guatemala Honduras El Salvador Nicaragua Costa Rica Panama Dominican Republic Jamaica Trinidad & Tobago Guatemala Honduras El Salvador Nicaragua Costa Rica Panama Dominican Republic Belize Haiti Honduras Dominica Saint Lucia Grenada Antigua Barbuda Saint Vincent Grenadines Barbados Aruba Bahamas Turks & Caicos Islands Cayman Islands Bermuda Montserrat British Virgin Islands Anguilla St Kitts Nevis St Lucia Dominica Saint Vincent Grenadines Barbados Aruba Bahamas Turks & Caicos Islands Cayman Islands Bermuda Montserrat British Virgin Islands Anguilla St Kitts Nevis St Lucia Belize Haiti Honduras Dominica Saint Lucia Grenada Antigua Barbuda Saint Vincent Grenadines Barbados Aruba Bahamas Turks & Caicos Islands Cayman Islands Bermuda Montserrat British Virgin Island Anguilla St Kitts Nevis St Lucia Belize Haiti Honduras Dominica Saint Lucia Grenada Antigua Barbuda Saint Vincent Grenadines Barbados Aruba Bahamas Turks&Caicos Island Cayman Island Bermuda Montserrat British Virgin Island Anguilla St Kitts Nevis St Lucie.
Some Of The Growth Factors Of This Market:
- The LVP market is driven by the increasing number of patients suffering from chronic diseases, such as diabetes and cancer.
- Increasing prevalence of infectious diseases, such as HIV/AIDS and Hepatitis C, will also drive the growth of the LVP market.
- Increasing demand for immunoglobulin therapy in emerging markets will also drive the growth of the LVP market.
- Increasing incidence rates for chronic diseases in developing countries will fuel demand for immunoglobulin therapy.
Industry Growth Insights published a new data on “Large Volume Parenteral (LVP) Market”. The research report is titled “Large Volume Parenteral (LVP) Market research by Types (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), By Applications (Basic Infusion, Therapeutic Infusion, Nutritious Infusion), By Players/Companies Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Aspen Holdings, Beximco Pharma, Cook Pharmica, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Large Volume Parenteral (LVP) Market Research Report
By Type
Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP
By Application
Basic Infusion, Therapeutic Infusion, Nutritious Infusion
By Companies
Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Aspen Holdings, Beximco Pharma, Cook Pharmica, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Large Volume Parenteral (LVP) Market Report Segments:
The global Large Volume Parenteral (LVP) market is segmented on the basis of:
Types
Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Basic Infusion, Therapeutic Infusion, Nutritious Infusion
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter Healthcare
- Kelun Pharma
- B. Braun
- Fresenius
- Teva Pharmaceutical Industries
- Pfizer (Hospira)
- Ostuka Pharmaceutical
- CR Double-Crane
- Pisa
- Huaren
- Patheon
- Aspen Holdings
- Beximco Pharma
- Cook Pharmica
- Albert David
- PSI Ltd
- Ozon Pharmaceuticals
- BAG Healthcare
- BML Parenteral Drugs
 Market Overview.svg)
Highlights of The Large Volume Parenteral (LVP) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Soft Bag LVP
- Plastic Bottle LVP
- Glass Bottle LVP
- By Application:
- Basic Infusion
- Therapeutic Infusion
- Nutritious Infusion
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Large Volume Parenteral (LVP) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Large volume parenteral (LVP) is a type of intravenous infusion that delivers large volumes of fluid and/or medication over a period of time.
Some of the major players in the large volume parenteral (lvp) market are Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Aspen Holdings, Beximco Pharma, Cook Pharmica, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs.
The large volume parenteral (lvp) market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Large Volume Parenteral (LVP) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Large Volume Parenteral (LVP) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Large Volume Parenteral (LVP) Market - Supply Chain
4.5. Global Large Volume Parenteral (LVP) Market Forecast
4.5.1. Large Volume Parenteral (LVP) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Large Volume Parenteral (LVP) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Large Volume Parenteral (LVP) Market Absolute $ Opportunity
5. Global Large Volume Parenteral (LVP) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Large Volume Parenteral (LVP) Market Size and Volume Forecast by Type
5.3.1. Soft Bag LVP
5.3.2. Plastic Bottle LVP
5.3.3. Glass Bottle LVP
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Large Volume Parenteral (LVP) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Large Volume Parenteral (LVP) Market Size and Volume Forecast by Application
6.3.1. Basic Infusion
6.3.2. Therapeutic Infusion
6.3.3. Nutritious Infusion
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Large Volume Parenteral (LVP) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Large Volume Parenteral (LVP) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Large Volume Parenteral (LVP) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Large Volume Parenteral (LVP) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Large Volume Parenteral (LVP) Demand Share Forecast, 2019-2026
9. North America Large Volume Parenteral (LVP) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Large Volume Parenteral (LVP) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Large Volume Parenteral (LVP) Market Size and Volume Forecast by Application
9.4.1. Basic Infusion
9.4.2. Therapeutic Infusion
9.4.3. Nutritious Infusion
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Large Volume Parenteral (LVP) Market Size and Volume Forecast by Type
9.7.1. Soft Bag LVP
9.7.2. Plastic Bottle LVP
9.7.3. Glass Bottle LVP
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Large Volume Parenteral (LVP) Demand Share Forecast, 2019-2026
10. Latin America Large Volume Parenteral (LVP) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Large Volume Parenteral (LVP) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Large Volume Parenteral (LVP) Market Size and Volume Forecast by Application
10.4.1. Basic Infusion
10.4.2. Therapeutic Infusion
10.4.3. Nutritious Infusion
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Large Volume Parenteral (LVP) Market Size and Volume Forecast by Type
10.7.1. Soft Bag LVP
10.7.2. Plastic Bottle LVP
10.7.3. Glass Bottle LVP
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Large Volume Parenteral (LVP) Demand Share Forecast, 2019-2026
11. Europe Large Volume Parenteral (LVP) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Large Volume Parenteral (LVP) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Large Volume Parenteral (LVP) Market Size and Volume Forecast by Application
11.4.1. Basic Infusion
11.4.2. Therapeutic Infusion
11.4.3. Nutritious Infusion
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Large Volume Parenteral (LVP) Market Size and Volume Forecast by Type
11.7.1. Soft Bag LVP
11.7.2. Plastic Bottle LVP
11.7.3. Glass Bottle LVP
118. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Large Volume Parenteral (LVP) Demand Share, 2019-2026
12. Asia Pacific Large Volume Parenteral (LVP) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Large Volume Parenteral (LVP) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Large Volume Parenteral (LVP) Market Size and Volume Forecast by Application
12.4.1. Basic Infusion
12.4.2. Therapeutic Infusion
12.4.3. Nutritious Infusion
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Large Volume Parenteral (LVP) Market Size and Volume Forecast by Type
12.7.1. Soft Bag LVP
12.7.2. Plastic Bottle LVP
12.7.3. Glass Bottle LVP
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Large Volume Parenteral (LVP) Demand Share, 2019-2026
13. Middle East & Africa Large Volume Parenteral (LVP) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Large Volume Parenteral (LVP) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Large Volume Parenteral (LVP) Market Size and Volume Forecast by Application
13.4.1. Basic Infusion
13.4.2. Therapeutic Infusion
13.4.3. Nutritious Infusion
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Large Volume Parenteral (LVP) Market Size and Volume Forecast by Type
13.7.1. Soft Bag LVP
13.7.2. Plastic Bottle LVP
13.7.3. Glass Bottle LVP
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Large Volume Parenteral (LVP) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Large Volume Parenteral (LVP) Market: Market Share Analysis
14.2. Large Volume Parenteral (LVP) Distributors and Customers
14.3. Large Volume Parenteral (LVP) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Baxter Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Kelun Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B. Braun
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fresenius
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teva Pharmaceutical Industries
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer (Hospira)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ostuka Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. CR Double-Crane
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Pisa
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Huaren
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Patheon
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Aspen Holdings
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Beximco Pharma
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Cook Pharmica
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Albert David
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. PSI Ltd
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Ozon Pharmaceuticals
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. BAG Healthcare
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. BML Parenteral Drugs
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
